Home › Trial NCT00151320
Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL
- Trial IDNCT00151320
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorWeill Medical College of Cornell University
- Enrollment76
- Start date2004-01
- ConditionsNon-Hodgkin's Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.